Estrogens, Conjugated; Medroxyprogesterone Acetate Patent Expiration
Estrogens, Conjugated; Medroxyprogesterone Acetate was first introduced by Wyeth Pharmaceuticals Inc
Estrogens, Conjugated; Medroxyprogesterone Acetate Patents
Given below is the list of patents protecting Estrogens, Conjugated; Medroxyprogesterone Acetate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Premphase 14/14 | US5547948 | Controlled release of steroids from sugar coatings |
Jan 17, 2015
(Expired) | Wyeth Pharms |
| Prempro | US5547948 | Controlled release of steroids from sugar coatings |
Jan 17, 2015
(Expired) | Wyeth Pharms |
Estrogens, Conjugated; Medroxyprogesterone Acetate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List